Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) IPO
IPO
Priced at US$12.00 a share on Oct 8, 2026.
- Price
- US$12.00 a share
- Shares offered
- 3,750,000 shares of common stock
- Offering size
- US$45 million
- Underwriters' option
- Up to 562,500 more shares
- Listing
- RTSN on the Nasdaq Capital Market
- Underwriters
- Leerink Partners, Guggenheim Securities, Oppenheimer & Co., Titan Partners · In the order on the cover
- Shares delivered
- On or about Oct 13, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 17, 2026 |
| Filed publicly | Sep 18, 2026 |
| Amended twice | Newest Oct 7, 2026 |
| Shares registered with an exchange | Oct 8, 2026 |
| Declared effective by the SEC | Oct 8, 2026 |
| Final prospectus, with the price | Oct 9, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 9, 2026 |
| EFFECT · Notice that a registration is effective | Oct 8, 2026 |
| S-1MEF · Registration of more shares for the same offering | Oct 8, 2026 |
| CERT · Exchange's certificate of listing | Oct 8, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 8, 2026 |
| S-1/A · Registration statement, amended | Oct 7, 2026 |
| S-1/A · Registration statement, amended | Oct 5, 2026 |
| S-1 · Registration statement | Sep 18, 2026 |
| DRS/A · Draft registration statement, amended | Aug 14, 2026 |
| DRS/A · Draft registration statement, amended | Jun 16, 2026 |
| DRS/A · Draft registration statement, amended | May 1, 2026 |
| DRS · Draft registration statement | Feb 17, 2026 |
From the cover of the final prospectus (424B4) filed Oct 9, 2026